EGFR and non-small cell lung carcinoma: NSCLC exhibits notable molecular heterogeneity, with key driver gene mutations including epidermal growth factor receptor (EGFR), kirsten ratsarcoma viral oncogene homolog (KRAS) and anaplastic lymphoma kinase.